Advertisement

Picture Berlin Partner Top News CRIPSR Repairs Immune Cells 650x100px
Organisation › Details

Généthon (FR)

Généthon, created by the AFM-Telethon, has the mission to make innovative gene therapy treatments available to patients affected with rare genetic diseases. Having played a pioneering role in deciphering the human genome, Généthon is today, with more than 200 scientists, physicians, engineers and regulatory affairs specialists, one of the leading organizations for the development of gene therapy treatments. Généthon has also built one of the largest sites worldwide for GMP production of gene therapy products, Généthon Bioprod. In 2012, Généthon was awarded the prestigious Prix Galien for Pharmaceutical Research (France). In 2015, Généthon was one of 16 winners of the World Innovation Competition 2030 for its project on the development of an industrial process for production of gene therapy vectors. The pipeline of Généthon includes products currently in international clinical trials and at preclinical stages, for immune deficiencies, muscular dystrophies, ocular and liver diseases. These products are developed either with Généthon as sponsor, or in partnership with private companies and academic institutions. *

 

Period Start 1990-12-08 start
  Group French Myopathy Association (AFM)
Products Industry gene therapy
  Industry 2 DRUGS, ORPHAN
Persons Person Revah, Frédéric (Généthon 201001– CEO before Sepal Pharma CEO + Cerep)
  Person 2 Vick, Jeffery S. (Jeff) (Généthon 201509 Director BusDev before Flamel Technologies + Silence Therapeutics)
     
Region Region Évry, Essonne
  Country France
  Street 1 rue de l’Internationale
BP60
  City 91002 Évry
  Tel +33-1-6947-2828
    Address record changed: 2020-12-02
     
Basic data Employees D: 101 to 500 (2015-12-16)
     
    * Document for »About Section«: 
     
   
Record changed: 2024-02-12

Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for French Myopathy Association (AFM)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Berlin Partner Top News How Covid Effects the Brain 650x300px




» top